Purpose: To determine the most cost-effective colorectal cancer screening strategy costing less than $100,000 per life-year saved and to determine how available strategies compare with each other.
Materials And Methods: Standardized methods were used to calculate incremental cost-effectiveness ratios (ICERs) from published estimates of cost and effectiveness of colorectal cancer screening strategies, and the direction and magnitude of any effect on the ratio from parameter estimate adjustments based on literature values were estimated.
Results: Strategies in which double-contrast barium enema examination was performed emerged as optimal from all studies included. In average-risk individuals, screening with double-contrast barium enema examination every 3 years, or every 5 years with annual fecal occult blood testing, had an ICER of less than $55,600 per life-year saved. However, double-contrast barium enema examination screening every 3 years plus annual fecal occult blood testing had an ICER of more than $100,000 per life-year saved. Colonoscopic screening had an ICER of more than $100,000 per life-year saved, was dominated by other screening strategies, and offered less benefit than did double-contrast barium enema examination screening.
Conclusion: Double-contrast barium enema examination can be a cost-effective component of colorectal cancer screening, but further modeling efforts are necessary.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1148/radiology.219.1.r01ap3144 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Conservative Management of Bowel Endometriosis: Cross-Sectional Analysis for Assessing Clinical Outcomes and Quality-of-Life.
J Clin Med
November 2024
Unit of Obstetrics and Gynecology, P.O. "Ospedale del Tigullio"-ASL4, Via G. B. Ghio 9, Metropolitan Area of Genoa, 16043 Chiavari, Italy.
: Bowel endometriosis (BE) is characterized by the presence of endometrial-like tissue within the muscular layer of the bowel wall. When BE does not result in the severe obstruction to fecal transit and in the absence of (sub)occlusive symptoms, the decision to perform surgery can be challenging, as intestinal procedures are associated with higher complication rates and long-term bowel dysfunction. This cross-sectional study aims to evaluate the quality of life (QoL) in patients with BE who avoided surgery, as well as to investigate the impact of the characteristics of BE nodules on the QoL and intestinal function.
View Article and Find Full Text PDFEvaluating the effect of NPO status on mucosal coating during double contrast barium esophagrams.
Abdom Radiol (NY)
October 2024
Department of Radiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Introduction: Current guidelines for double contrast barium esophagography studies (BAS) suggest that patients should be nil per os (NPO) prior to completing BAS for optimal esophageal coating, although the time required varies between practices and institutions. It is believed that consumption of food or water disrupts the ability for thick barium contrast to properly coat the esophageal mucosa. Exams that are rescheduled for this reason can lead to delays in care, without substantial evidence that NPO status truly affects esophageal mucosal coating for these exams with current barium mixtures.
View Article and Find Full Text PDFNational cancer screening program for colorectal cancer in Korea.
Ann Surg Treat Res
December 2023
Division of Colorectal Surgery, Department of Surgery, Ewha Womans University College of Medicine, Seoul, Korea.
Article Synopsis
- * The study evaluates the National Cancer Screening Program, highlighting the switch from fecal occult blood tests (FOBT) to fecal immunochemical tests (FIT) for better screening effectiveness.
- * Despite a stable screening rate, there is potential for improvement, and it may be time to update screening guidelines to cater to Korea’s aging population.
Colon Cancer Screening Methods: 2023 Update.
Cureus
April 2023
Medicine, GMERS Medical College and Hospital, Dharpur-Patan, Patan, IND.
Colorectal cancer (CRC) is a significant cause of morbidity and mortality worldwide. National screening guidelines have been implemented to identify and remove precancerous polyps before they become cancer. Routine CRC screening is advised for people with average risk starting at age 45 because it is a common and preventable malignancy.
View Article and Find Full Text PDFDouble-contrast barium enema is no longer justified as a backup examination for colonoscopy in the population screening program: Population study in an organized fecal immunochemical test-based screening program.
J Gastroenterol Hepatol
August 2023
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Background And Aim: Currently, some countries still acknowledge double-contrast barium enema (DCBE) as a backup confirmatory examination when colonoscopy is not feasible or incomplete in colorectal cancer (CRC) screening programs. This study aims to compare the performance of colonoscopy and DCBE in terms of the risk of incident CRC after negative results in the fecal immunochemical test (FIT)-based Taiwan Colorectal Cancer Screening Program.
Methods: Subjects who had positive FITs and received confirmatory exams, either colonoscopy or DCBE, without the findings of neoplastic lesions from 2004 to 2013 in the screening program comprised the study cohort.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!